Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.

Jacoby MA, Spencer DH, Gao F, Uy GL, Burton T, Heath SE, Du F, O'Laughlin M, Fulton RS, Miller CA, Duncavage EJ, Schroeder MA, Ghobadi A, Pusic I, Stockerl-Goldstein KE, Kahl BS, Cashen AF, Christopher MJ, Singh N, Vij R, Crees ZD, Wartman LD, Day RB, Fehniger TA, Oetjen KA, Patel DA, Kim MY, Slade MJ, Ferraro F, Walter MJ, Abboud CN, Abboud R, Link DC, Al-Mansour ZA, Cogle CR, Huselton EJ, DiPersio JF, Westervelt P, Ley TJ

Open source

DOI
10.1056/evidoa2500352
Published
2026 Sep
Container
NEJM evidence
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2500352,
  title = {Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.},
  author = {Jacoby MA and Spencer DH and Gao F and Uy GL and Burton T and Heath SE and Du F and O'Laughlin M and Fulton RS and Miller CA and Duncavage EJ and Schroeder MA and Ghobadi A and Pusic I and Stockerl-Goldstein KE and Kahl BS and Cashen AF and Christopher MJ and Singh N and Vij R and Crees ZD and Wartman LD and Day RB and Fehniger TA and Oetjen KA and Patel DA and Kim MY and Slade MJ and Ferraro F and Walter MJ and Abboud CN and Abboud R and Link DC and Al-Mansour ZA and Cogle CR and Huselton EJ and DiPersio JF and Westervelt P and Ley TJ},
  year = {2026},
  journal = {NEJM evidence},
  doi = {10.1056/evidoa2500352},
  url = {https://doi.org/10.1056/evidoa2500352}
}

RIS

TY  - JOUR
TI  - Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.
AU  - Jacoby MA
AU  - Spencer DH
AU  - Gao F
AU  - Uy GL
AU  - Burton T
AU  - Heath SE
AU  - Du F
AU  - O'Laughlin M
AU  - Fulton RS
AU  - Miller CA
AU  - Duncavage EJ
AU  - Schroeder MA
AU  - Ghobadi A
AU  - Pusic I
AU  - Stockerl-Goldstein KE
AU  - Kahl BS
AU  - Cashen AF
AU  - Christopher MJ
AU  - Singh N
AU  - Vij R
AU  - Crees ZD
AU  - Wartman LD
AU  - Day RB
AU  - Fehniger TA
AU  - Oetjen KA
AU  - Patel DA
AU  - Kim MY
AU  - Slade MJ
AU  - Ferraro F
AU  - Walter MJ
AU  - Abboud CN
AU  - Abboud R
AU  - Link DC
AU  - Al-Mansour ZA
AU  - Cogle CR
AU  - Huselton EJ
AU  - DiPersio JF
AU  - Westervelt P
AU  - Ley TJ
PY  - 2026
JO  - NEJM evidence
DO  - 10.1056/evidoa2500352
UR  - https://doi.org/10.1056/evidoa2500352
ER  - 

APA

MA, J., DH, S., F, G., GL, U., T, B., SE, H., F, D., M, O., RS, F., CA, M., EJ, D., MA, S., A, G., I, P., KE, S., BS, K., AF, C., MJ, C., N, S., R, V., ZD, C., LD, W., RB, D., TA, F., KA, O., DA, P., MY, K., MJ, S., F, F., MJ, W., CN, A., R, A., DC, L., ZA, A., CR, C., EJ, H., JF, D., P, W., & TJ, L. (2026). Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.. NEJM evidence. https://doi.org/10.1056/evidoa2500352

Source records